Informations techniques
Exploitant
LUPIN EUROPE GmbH
Présentation
NAMUSCLA 167 mg, gélule
B/30 (CIP : 34009 301 721 2 4)
B/50 (CIP : 34009 301 721 3 1)
B/100 (CIP : 34009 301 721 4 8)
B/200 (CIP : 34009 550 625 8 5)
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
PbPFb9HkJtVqVcHQ
Français